Cargando…

Activity of FAAH-Inhibitor JZP327A in an Experimental Rat Model of Migraine

Increased anandamide levels via fatty acid amide hydrolase (FAAH) inhibition can decrease the pronociceptive responses and inflammatory mediators in animal models of migraine. Here, we profile the pharmacological activity of the FAAH inhibitor JZP327A, a chiral 1,3,4-oxadiazol-2(3H)-one compound, in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Greco, Rosaria, Francavilla, Miriam, Demartini, Chiara, Zanaboni, Anna Maria, Facchetti, Sara, Palmisani, Michela, Franco, Valentina, Tassorelli, Cristina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10299064/ https://www.ncbi.nlm.nih.gov/pubmed/37373250 http://dx.doi.org/10.3390/ijms241210102

Ejemplares similares

Dual Inhibition of FAAH and MAGL Counteracts Migraine-like Pain and Behavior in an Animal Model of Migraine
por: Greco, Rosaria, et al.
Publicado: (2021)

Characterization of the biochemical and behavioral effects of cannabidiol: implications for migraine
por: Greco, Rosaria, et al.
Publicado: (2023)

Correction: Characterization of the biochemical and behavioral effects of cannabidiol: implications for migraine
por: Greco, Rosaria, et al.
Publicado: (2023)

Antagonism of CGRP Receptor: Central and Peripheral Mechanisms and Mediators in an Animal Model of Chronic Migraine
por: Greco, Rosaria, et al.
Publicado: (2022)

Biomarkers of Migraine: An Integrated Evaluation of Preclinical and Clinical Findings
por: Demartini, Chiara, et al.
Publicado: (2023)

URB937 Prevents the Development of Mechanical Allodynia in Male Rats with Trigeminal Neuralgia
por: Demartini, Chiara, et al.
Publicado: (2023)

Endocannabinoid System and Migraine Pain: An Update
por: Greco, Rosaria, et al.
Publicado: (2018)

Modulation of Glia Activation by TRPA1 Antagonism in Preclinical Models of Migraine
por: Demartini, Chiara, et al.
Publicado: (2022)

Potentiation of endocannabinoids and other lipid amides prevents hyperalgesia and inflammation in a pre-clinical model of migraine
por: Greco, Rosaria, et al.
Publicado: (2022)

Oculo-vestibular signs in experimentally induced migraine attacks: an exploratory analysis
por: Corrado, Michele, et al.
Publicado: (2022)

The role of the transient receptor potential ankyrin type-1 (TRPA1) channel in migraine pain: evaluation in an animal model
por: Demartini, Chiara, et al.
Publicado: (2017)

Spinal nociceptive sensitization and plasma palmitoylethanolamide levels during experimentally induced migraine attacks
por: De Icco, Roberto, et al.
Publicado: (2021)

Plasma levels of CGRP and expression of specific microRNAs in blood cells of episodic and chronic migraine subjects: towards the identification of a panel of peripheral biomarkers of migraine?
por: Greco, Rosaria, et al.
Publicado: (2020)

Chronic and intermittent administration of systemic nitroglycerin in the rat induces an increase in the gene expression of CGRP in central areas: potential contribution to pain processing
por: Greco, Rosaria, et al.
Publicado: (2018)

Evaluation of ADMA-DDAH-NOS axis in specific brain areas following nitroglycerin administration: study in an animal model of migraine
por: Greco, Rosaria, et al.
Publicado: (2015)

Antagonism of Transient Receptor Potential Ankyrin Type-1 Channels as a Potential Target for the Treatment of Trigeminal Neuropathic Pain: Study in an Animal Model
por: Demartini, Chiara, et al.
Publicado: (2018)

P007. Inhibition of monoacylglycerol lipase activity modulates the activation of brain structures relevant for migraine pathogenesis
por: Greco, Rosaria, et al.
Publicado: (2015)

CD163 as a Potential Biomarker of Monocyte Activation in Ischemic Stroke Patients
por: Greco, Rosaria, et al.
Publicado: (2021)

Double-Binding Botulinum Molecule with Reduced Muscle Paralysis: Evaluation in In Vitro and In Vivo Models of Migraine
por: Andreou, Anna P., et al.
Publicado: (2020)

Effects of anandamide in migraine: data from an animal model
por: Greco, Rosaria, et al.
Publicado: (2011)

FAAH inhibitors in the limelight, but regrettably
por: Mallet, Christophe, et al.
Publicado: (2016)

Activation of CB2 receptors as a potential therapeutic target for migraine: evaluation in an animal model
por: Greco, Rosaria, et al.
Publicado: (2014)

Health Tract No. 327: The Pulse
Publicado: (1868)

Potent dual MAGL/FAAH inhibitor AKU-005 engages endocannabinoids to diminish meningeal nociception implicated in migraine pain
por: Della Pietra, Adriana, et al.
Publicado: (2023)

Population Pharmacokinetic Model Development and Simulation for Recombinant Erwinia Asparaginase Produced in Pseudomonas fluorescens (JZP‐458)
por: Lin, Tong, et al.
Publicado: (2021)

Population pharmacokinetics of intramuscular recombinant Erwinia chrysanthemi asparaginase (JZP458) in patients with acute lymphoblastic leukemia
por: Lin, Tong, et al.
Publicado: (2023)

Potential Therapeutic Value of a Novel FAAH Inhibitor for the Treatment of Anxiety
por: Marco, Eva M., et al.
Publicado: (2015)

FAAH selectively influences placebo effects
por: Peciña, M., et al.
Publicado: (2013)

The endocannabinoid hydrolase FAAH is an allosteric enzyme
por: Dainese, Enrico, et al.
Publicado: (2020)

Distinct Activity of Endocannabinoid-Hydrolyzing Enzymes MAGL and FAAH in Key Regions of Peripheral and Central Nervous System Implicated in Migraine
por: Della Pietra, Adriana, et al.
Publicado: (2021)

A polymorphism in the gene of the endocannabinoid-degrading enzyme FAAH (FAAH C385A) is associated with emotional–motivational reactivity
por: Conzelmann, Annette, et al.
Publicado: (2012)

Experimentally induced spinal nociceptive sensitization increases with migraine frequency: a single-blind controlled study
por: De Icco, Roberto, et al.
Publicado: (2020)

Comparative results of 327 chemical carcinogenicity studies.
por: Haseman, J K, et al.
Publicado: (1987)

Molecular Basis for Non-Covalent, Non-Competitive FAAH Inhibition
por: Morgillo, Carmine Marco, et al.
Publicado: (2022)

Recombinant Erwinia asparaginase (JZP458) in acute lymphoblastic leukemia: results from the phase 2/3 AALL1931 study
por: Maese, Luke, et al.
Publicado: (2023)

Analgesic effects of FAAH inhibitor in the insular cortex of nerve-injured rats
por: Jee Kim, Min, et al.
Publicado: (2018)

Role of FAAH-Like Anandamide Transporter in Anandamide Inactivation
por: Leung, KwanNok, et al.
Publicado: (2013)

Author Correction: The endocannabinoid hydrolase FAAH is an allosteric enzyme
por: Dainese, Enrico, et al.
Publicado: (2020)

Long-term study of the safety and maintenance of efficacy of solriamfetol (JZP-110) in the treatment of excessive sleepiness in participants with narcolepsy or obstructive sleep apnea
por: Malhotra, Atul, et al.
Publicado: (2019)

A Randomized Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Recombinant Erwinia Asparaginase (JZP‐458) in Healthy Adult Volunteers
por: Lin, Tong, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0gqd8npe1cbb0t960t9d4bhjn3